Aug 5, 2025, 09:17 AM by

New research from the COPD Foundation and Phreesia shows patients with chronic obstructive pulmonary disease (COPD) face significant challenges, but conversations with healthcare providers can play a critical role in helping patients understand their condition, set realistic goals, ease symptom burden and improve their quality of life.

Aug 5, 2025, 09:17 AM by

Former Covera Health CTO to lead technology and product strategy at Advarra, driving innovation in clinical research

Aug 5, 2025, 09:17 AM by

Aug 5, 2025, 09:17 AM by

I wanted to share that Software-as-a-Service (SaaS) security leader, AppOmni today announced new innovations to combat rising AI and SaaS risks for healthcare companies: https://appomni.com/press-releases/saas-ai-security-innovation Please let me know if you’d like to speak with them for more about the benefits for healthcare, get a product image, or if I can provide anything further. The rapid adoption of AI has introduced a new and complex attack surface that healthcare cybersecurity teams must manage. AI is an active participant in the SaaS environment; whether embedded in SaaS platforms (such as M365 or Google Workspace) or acting as agents, AI tools constantly access and process sensitive data across the SaaS estate. Healthcare organizations need the ability to identify unsanctioned or shadow AI and SaaS usage, as well as practical strategies to control and monitor AI usage. AppOmni is defining the future of SaaS and AI security by arming organizations of all sizes with the end-to-end controls needed for safe usage of these applications, helping them identify critical risks, protect sensitive data, detect abnormal behavior, and respond to evolving threats. The new features help healthcare understand their risk exposure to AI and implement controls to secure them by identifying both sanctioned and unsanctioned/ shadow AI apps, including AI embedded within SaaS applications. It’s also adding support for 30 new AI and SaaS applications, including ChatGPT Enterprise, Claude, OpenAI, and Anthropic, Cisco Umbrella, Cisco Secure Access, and Gong. And it’s giving healthcare organizations a free 90-day trial of its new AppOmni Foundations package – a SaaS security starter solution for organizations that need to discover shadow SaaS and AI, app users and permission, and detect threats and anomalous activities.

Aug 5, 2025, 09:17 AM by

InSysBio announces Immune Response Template (IRT) which was previously available under a license model now is completely free to use. IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system.

Aug 5, 2025, 01:00 AM by User Not Found

Bio-IT World | A new biotech company launched last month with a novel approach to protein discovery that could transform how researchers identify biomarkers and develop treatments for cardiovascular disease, cancer, and neurodegenerative conditions. XProteome, founded by Michigan State University researcher Morteza Mahmoudi, has developed an integrated platform that combines nanomedicine, artificial intelligence, and causality analysis to pinpoint disease-causing proteins with unprecedented precision.

Aug 4, 2025, 08:46 AM by

iRhythm and Lucem Health Partner to Introduce Predictive AI Solution for Early Detection of Arrhythmias in Patient Populations with Comorbid Conditions

Jul 31, 2025, 09:29 AM by

Jul 31, 2025, 09:29 AM by

Jul 31, 2025, 09:29 AM by

Clinisys announces the acquisition of Orchard Software from Francisco Partners, a leading global investment firm that specializes in partnering with technology businesses. The acquisition brings together two leaders in the LIS market and reaffirms Clinisys’s continued commitment to provide the laboratory informatics marketplace with cutting edge software advancements.

Jul 31, 2025, 09:29 AM by

MAGENTIQ EYE Secures Series A Investment Led by aMoon to Drive the Future of AI-Powered Gastroenterology

Jul 31, 2025, 01:00 AM by User Not Found

Bio-IT World | The Longitude Prize on ALS, presented at this year’s Bio-IT World Conference & Expo, has launched to incentivize and reward cutting edge AI-based approaches to transform drug discovery for the treatment of ALS (amyotrophic lateral sclerosis); UK Biobank completed the world’s largest whole body imaging project; and more.

Jul 30, 2025, 12:06 PM by

Camgenium today announced its partnership with Professor Petre Cristian Ilie, Consultant Urological and Robotic Surgeon at NNUH NHS Foundation Trust, to develop HealthiumPro, a cloud-based innovative software solution. The system has the potential to improve the outcomes of prostate cancer patients by enhancing safety before and after surgery.

Jul 30, 2025, 12:06 PM by

Compact Vertical Lift Module Engineered for Low-Height Environments with Intelligent Inventory Control

Jul 30, 2025, 01:00 AM by User Not Found

Bio-IT World | Centivax plans to get their first universal flu vaccine through a Phase I clinical trial; Portal Biotech will use their nanopore-based platform technology to deliver rapid, full-length, single-molecule protein characterization and expand its R&D, engineering, and data-science teams; and more.

Jul 29, 2025, 09:02 AM by

AMP announced the recipients of its 2025 Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership and Meritorious Service Awards.

Jul 29, 2025, 01:00 AM by User Not Found

Bio-IT World | Researchers have published the first draft Arab pangenome reference, the UAE Pangenome Reference (UPR) based on 53 individuals of diverse Arab ethnicities residing in the United Arab Emirates. The work was done at the Center for Applied and Translational Genomics (CATG), Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai Health, Dubai, United Arab Emirates and was published in Nature Communications last week.

Jul 25, 2025, 09:15 AM by

Jul 25, 2025, 09:15 AM by

Jul 24, 2025, 09:19 AM by

START enhances its global leadership by integrating Advarra’s advanced regulatory and technology solutions, creating a seamlessly connected site network to accelerate trials and relieve pressure on the oncology drug development ecosystem.